C. Lu

发表

Modelling the cost-effectiveness of sentinel lymph node mapping and adjuvant interferon treatment for stage II melanoma

C. Yen, L. Wilson, C. Reyes, 2002, Melanoma research.

A phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small cell lung cancer.

F. Khuri, W. Hong, R. Herbst, 2001, Lung cancer.

Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy.

D. Gomez, J. Welsh, R. Komaki, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Pharmacokinetic study of the phase III, randomized, double-blind, multicenter trial of paclitaxel (Pac) and carboplatin (C) combined with erlotinib (E) or placebo in patients with advanced non-small cell lung cancer(NSCLC).

R. Herbst, V. Papadimitrakopoulou, H. Tran, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The interpretation of 131I scans in the evaluation of thyroid cancer, with an emphasis on false positive findings.

I. Mcdougall, C. Lu, M. Carlisle, 2003, Nuclear medicine communications.

The role of computed tomography of the chest in the management of small-cell lung cancer.

E. Fishman, S. Siegelman, N. Khouri, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ZD6474, a novel antiangiogenic agent, in combination with docetaxel in patients with NSCLC: Results of the run-in phase of a two-part, randomized phase II study.

R. Herbst, P. Fidias, J. Heymach, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term results of salvage cryotherapy for prostate cancer.

J. Chin, S. Pautler, C. Lu, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Expression of methylation-related genes is associated with overall survival in patients with non-small cell lung cancer

M. Spitz, J. Gu, Xifeng Wu, 2008, British Journal of Cancer.

A randomized phase II/III trial of a tumor vascular disrupting agent fosbretabulin tromethamine (CA4P) with carboplatin (C) and paclitaxel (P) in anaplastic thyroid cancer (ATC): Final survival analysis for the FACT trial.

F. Khuri, A. Gramza, B. Haugen, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinoma.

J. Lee, H. Tran, L. Ginsberg, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II clinical trial of suberoylanilide hydroxamic acid (SAHA) in patients (pts) with recurrent and/or metastatic head and neck cancer(SCCHN).

A. Gillenwater, V. Papadimitrakopoulou, M. Kies, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pathogenic Mutations in ATM Predict for Enhanced Local Control in Prostate Cancers Treated with Radiation Thearpy

M. Zelefsky, J. Reis-Filho, T. Chan, 2018, International Journal of Radiation Oncology*Biology*Physics.

CT quantitative analysis study for angiogenesis, and degree of ischemic necrosis and glucose metabolite in non-small cell lung cancer.

X. Shan, J-H. Chen, C. Lu, 2018, European Review for Medical and Pharmacological Sciences.

Induction chemotherapy (CT) with weekly paclitaxel, carboplatin, and cetuximab for squamous cell carcinoma of the head and neck (HN).

A. Garden, V. Papadimitrakopoulou, M. Kies, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II/III study of rogaratinib versus chemotherapy in patients with locally advanced or metastatic urothelial carcinoma selected based on FGFR1/3 mRNA expression.

C. Sternberg, D. Petrylak, J. Bellmunt, 2018, Annals of Oncology.

Pathogenic Mutations in ATM As Determinants of Local Control in Non-Small Cell Lung Cancers Treated with Radiation Therapy

J. Reis-Filho, N. Lee, N. Riaz, 2018, International Journal of Radiation Oncology*Biology*Physics.

Phase II study of dasatinib in the treatment of head and neck squamous cell carcinoma (HNSCC).

A. Sabichi, B. Bekele, L. Ginsberg, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.